课题基金 / 基金详情

Novel mechanism for the angiogenesis in hepatocellular carcinoma

Novel mechanism for the angiogenesis in hepatocellular carcinoma
肝细胞癌血管生成的新机制
批准号:
20590780
负责人:
SHIRAHA Hidenori
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

SHIRAHA Hidenori的其他基金

相似基金

相关文献

中文摘要
翻译
des - γ羧基凝血酶原(DCP)刺激人脐静脉上皮细胞KDR;增强细胞迁移2.2倍,增强细胞增殖1.5倍。KDR抑制剂消除了这些影响。序列分析显示,外显子2跳剪接变异γ -谷氨酰羧化酶(Δ2-GGCX)在dcp阳性的肝细胞癌(HCC)中表达。dcp阳性HCC细胞占Δ2-GGCX的69%,而dcp阴性HCC细胞占Δ2-GGCX的8%。Δ2-GGCX的引入将dcp阴性HCC细胞转化为dcp阳性HCC细胞。另一方面,野生型(WT)-GGCX的引入将dcp阳性HCC细胞转化为dcp阴性HCC细胞。将表达Hep3B的WT-GGCX和Δ2-GGCX细胞皮下注射到裸鼠体内。Δ2-GGCX-Hep3B形成的血管生成肿瘤比WT-GGCX-Hep3B大4.2倍。肝细胞癌组织样本显示,CD31指数测定的DCP生成与血管生成呈正相关。高血管型肝细胞癌血清DCP水平明显高于低血管型肝细胞癌。综上所述,DCP的表达与HCC中的肿瘤血管生成有关。
英文摘要
Des-gamma carboxy prothrombin (DCP) stimulated KDR in human umbilical vein epithelial cell ; enhanced cell migration by 2.2-fold and enhanced cell proliferation by 1.5-fold. KDR inhibitor abrogated these effects. Sequence analysis revealed that exon 2 skipping splice variant gamma-glutamyl carboxylase (Δ2-GGCX) was expressed in DCP-positive hepatocellular carcinoma (HCC) cells. DCP-positive HCC cells expressed 69% of Δ2-GGCX, while DCP-negative HCC cells expressed 8% of Δ2-GGCX. The introduction of Δ2-GGCX converted DCP-negative HCC cells into DCP-positive HCC cells. On the other hand, the introduction of wild type (WT)-GGCX converted DCP-positive HCC cells into DCP-negative HCC cells. WT-GGCX and Δ2-GGCX expressing Hep3B cells were injected subcutaneously into nude mice. Δ2-GGCX-Hep3B formed more angiogenic tumors and 4.2-fold larger tumors than WT-GGCX-Hep3B. HCC tissue samples demonstrated a positive correlation between DCP production and angiogenesis determined by CD31 index. The serum DCP level of hypervascular HCC was significantly higher than that of hypovascular HCC. In toto, DCP expression is associated with tumor angiogenesis in HCC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Des-gamma-carboxy prothrombin and angiogenesis in hepatocellular carcinoma.
肝细胞癌中的脱γ-羧基凝血酶原和血管生成。
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [Sumida Y, Yoneda M, Hyogo H, Yamaguchi K, Ono M, 白羽英則]
通讯作者: 白羽英則
カルボキシラーゼ活性によるEMT制御
通过羧化酶活性控制 EMT
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: [岡上武, 西原利治, 小野正文, 白羽英則]
通讯作者: 白羽英則
肝癌の分子標的治療
肝癌的分子靶向治疗
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [白羽英則]
通讯作者: 白羽英則
DOI: --
发表时间: 2010
期刊: Hepatogastroenterology. 57(97)巻
影响因子: --
作者: [Nouso K, Kobayashi Y, Nakamura S, Shiraha H, Yamamoto K, et.al.]
通讯作者: et.al.
共 22 条
    The novel anti-angiogenic therapy for hepatocellular carcinoma.
    • 批准号:
      23590975
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      SHIRAHA Hidenori
    • 依托单位:
    Development of in vitro NASH model using hepatocyte spheroid.
    • 批准号:
      18590735
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.27万
    • 财政年份:
      2006
    • 负责人:
      SHIRAHA Hidenori
    • 依托单位:
    Liver regeneration was affected by carboxylase gene transfer.
    • 批准号:
      16390210
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.9万
    • 财政年份:
      2004
    • 负责人:
      SHIRAHA Hidenori
    • 依托单位:
    海外基金